Latest filing published 12 Jan 2011 for ACCENTIA BIOPHARMACEUTICALS INC.
Insider track record
No signal scores available.
Alan M. Pearce: trading record in brief
Alan M. Pearce discloses dealings in 2 companies, chiefly Accentia Biopharmaceuticals Inc and Biovest International Inc. In total, 6 filings cover trades dated from 24 November 2010 to 10 January 2011.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 12 January 2011 came the latest disclosure, a share grant in Accentia Biopharmaceuticals Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Alan M. Pearce
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 66,000 sharesCommon StockSEC:0001181431-11-003303:0
- 56,000 sharesCommon StockSEC:0001181431-11-003304:0
- 100,000 shares@ US$0.06Common StockSEC:0001181431-11-003304:1
- 206,896 shares0Common StockSEC:0001181431-10-063091:0
- 750,000 shares0Common StockSEC:0001181431-10-057910:0
- 202,963 shares0Common StockSEC:0001181431-10-057909:0
6 of 6 declarations